190 related articles for article (PubMed ID: 21700544)
1. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine.
Bel B; Lorton MH; Darut-Jouve A; Vabres P
Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544
[No Abstract] [Full Text] [Related]
2. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer.
Gambill BD
Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375
[No Abstract] [Full Text] [Related]
3. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
Serrão VV; Feio AB
Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
[No Abstract] [Full Text] [Related]
4. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer.
Ben-Josef E
Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061
[TBL] [Abstract][Full Text] [Related]
5. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
Mayer RJ
J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
[No Abstract] [Full Text] [Related]
6. Capecitabine-induced inflammation of actinic keratosis: case report and literature review.
Stanciu M; Aubut N; Gagné E; Thibeault MM
J Cutan Med Surg; 2012; 16(5):298-9. PubMed ID: 22971302
[No Abstract] [Full Text] [Related]
7. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
Porschen R
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
[No Abstract] [Full Text] [Related]
8. Successful treatment with low-dose capecitabine for disseminated esophageal adenocarcinoma.
Carstens H; Albertsson M
Acta Oncol; 2007; 46(6):866-8. PubMed ID: 17653915
[No Abstract] [Full Text] [Related]
9. Capecitabine in the treatment of colorectal cancer.
O'Neill VJ; Cassidy J
Future Oncol; 2005 Apr; 1(2):183-90. PubMed ID: 16555988
[TBL] [Abstract][Full Text] [Related]
10. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine: an overview of the side effects and their management.
Saif MW; Katirtzoglou NA; Syrigos KN
Anticancer Drugs; 2008 Jun; 19(5):447-64. PubMed ID: 18418212
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine in carcinoma of the pancreas.
Smith DB; Neoptolemos JP
Expert Opin Pharmacother; 2006 Aug; 7(12):1633-9. PubMed ID: 16872266
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine.
Schellens JH
Oncologist; 2007 Feb; 12(2):152-5. PubMed ID: 17296810
[No Abstract] [Full Text] [Related]
14. Capecitabine-induced terminal ileitis.
Al-Gahmi AM; Kerr IG; Zekri JM; Zagnoon AA
Ann Saudi Med; 2012; 32(6):661-2. PubMed ID: 23396034
[No Abstract] [Full Text] [Related]
15. Capecitabine-induced acute myeloid leukaemia.
Tansley S; Gibbons S
N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
[No Abstract] [Full Text] [Related]
16. Novel approach to Gorlin syndrome: a patient treated with oral capecitabine.
Beach DF; Somer R
J Clin Oncol; 2011 May; 29(14):e397-401. PubMed ID: 21357787
[No Abstract] [Full Text] [Related]
17. Severe hypertriglyceridaemia associated with the use of capecitabine.
Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
[No Abstract] [Full Text] [Related]
18. The use of capecitabine in the combined-modality therapy for rectal cancer.
Liauw SL; Minsky BD
Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
20. Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine.
Ramani VS; Sun Myint A; Montazeri A; Wong H
Colorectal Dis; 2010 Aug; 12 Suppl 2():37-46. PubMed ID: 20618366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
